Skip to main content
. Author manuscript; available in PMC: 2015 Aug 3.
Published in final edited form as: Am J Ind Med. 2013 Sep 20;57(1):38–48. doi: 10.1002/ajim.22261

TABLE V.

Years of Potential Life Lost to Age 65 Years (YPLL65) byYear, United States, 1999–2010

Year Asbestosisa
Malignant mesotheliomab
Total
Deaths YPLL65
Deaths YPLL65
Deaths YPLL65
No. Median No. Median No. Median
1999 28 178 5.5 540 4,720 7.0 568 4,898 7.0
2000 35 215 5.0 517 4570 7.0 552 4,785 7.0
2001 39 221 6.0 520 4,689 7.0 559 4,910 7.0
2002 38 208 5.0 515 4,492 7.0 553 4,700 6.0
2003 44 284 5.0 553 4,930 7.0 597 5,214 7.0
2004 42 201 3.5 553 4,704 6.0 595 4,905 6.0
2005 38 223 5.0 566 4,626 7.0 604 4,849 6.0
2006 19 114 6.0 485 4,330 6.0 504 4,444 6.0
2007 28 129 4.0 511 4,104 6.0 539 4,233 6.0
2008 34 199 5.0 503 4,169 6.0 537 4,368 6.0
2009 24 111 3.5 491 3,801 6.0 515 3,912 6.0
2010 16 84 4.0 455 3,882 7.0 471 3,966 6.0

P-value for trend in deaths and YPLL for all conditions >0.05.

a

ICD-10 code (underlying cause): J61 (pneumoconios is due to asbestos and other mineral fibers) and deaths with underlying cause coded as J65 (pneumoconiosis associated with tuberculosis) or J92.0 (pleural plaques with presence of asbestos) with asbestosis as a contributing cause of death.

b

ICD-10 code (underlying cause): C45 (mesothelioma).